Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians.
Similarly How many shares of Zomedica are there? Share Statistics
| Avg Vol (3 month) 3 | 17.4M |
|---|---|
| Shares Outstanding 5 | 979.9M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 965.89M |
| % Held by Insiders 1 | 2.63% |
Should I invest in ZOM? ZOM stock is a risky bet in the pet diagnostics field, but it’s affordable and could provide powerful gains in the long-term. Or its downward spiral could continue; that’s a possibility which prospective investors should always consider.
Additionally, Why is ZOM stock down?
The reason behind the decline goes back into the previous week, when Zomedica announced its third-quarter results after the market close on Nov. 12. The veterinary health company reported revenue in the third quarter of only $22,514. It posted a net loss of $6.3 million, or $0.091 per share.
When did ZOM go public?
On April 18, 2019, the company became a public company via an initial public offering. After pricing at US$36 per share, the share price increased over 72% on the first day of trading. Prior to the IPO, Dropbox invested $5 million in Zoom.
Is ZOM a stock to buy? ZOM stock is a risky bet in the pet diagnostics field, but it’s affordable and could provide powerful gains in the long-term. Or its downward spiral could continue; that’s a possibility which prospective investors should always consider.
Is ZOM shorted? Short Shares Availability
This table shows the number of shares of US:ZOM available to be shorted at a leading prime brokerage. It is not the total number of shares available to short, nor is it the short interest.
Did Blackrock buy ZOM stock? – 13F, 13D, 13G Filings – Fintel.io.
…
BlackRock Inc. reports 29.83% decrease in ownership of ZOM / Zomedica Pharmaceuticals Corp.
| Security | ZOM / Zomedica Pharmaceuticals Corp. |
|---|---|
| Latest Disclosed Value | $ 3,896,000 |
Is Castor Maritime a good buy?
Castor Maritime Inc.
holds several positive signals and is within a strong rising trend. As the old saying says, « Let the trend be your friend. ‘ ». We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.
Is ZOM undervalued? InvestorPlace’s Mark Hake estimates Zomedica (NYSEAMERICAN:ZOM) is worth between $1.11 and $1.61 a share. That makes ZOM stock a buy at current prices.
Is Acasti Pharma a good stock to buy?
Is ACASTI PHARMA Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: ACST) stock is to Buy ACST stock.
Is Zomedica a pump and dump? Zomedica Pharmaceuticals (NYSEMKT:ZOM) stock is the latest pump-and-dump looking to take investors for a ride.
Will Zomedica get delisted?
The NYSE American LLC told Zomedica that it’s no longer in danger of being delisted. The exchange can remove a stock if it closes at less than $1 for more than 30 consecutive days. That’s no longer the case for Zomedica.
Is Zoom owned by China?
Zoom or Zoom Communications, Inc. is not a Chinese company at all but in fact, an American company founded by Chinese-American billionaire Eric Yuan. It is headquartered in San Jose, California and Yuan, who is also the CEO of Zoom, holds American citizenship.
Is Zoom Chinese owned? Zoom is a U.S.-founded company and its founder Eric Yuan is a Chinese immigrant who is now an American citizen. However, the company’s development team is “largely” based in China, according to Zoom’s regulatory filing from earlier this year.
Who are Zoom’s suppliers? In addition to beefing up its data centers, Zoom has also been increasing its capacity with its two cloud infrastructure providers, Amazon Web Services and Microsoft Azure, Steckelberg said. And the company is hiring engineers, as well as salespeople, despite that everyone is working from home.
Why is ZOM dropping?
CEO Robert Cohen said the move was precipitated by « changes at our current distributor that we believe have impacted its ability to market our products effectively. » Those words likely startled investors, many of whom decided to sell their shares. Zomedica’s stock price dropped sharply on Thursday.
Will NAKD stock recover? NAKD stock became a hit with the Reddit trading crowd and has done well to fortify its balance sheet. It’s now debt-free and has evolved into a pure-play e-commerce business. Unfortunately, there are several loopholes in its turnaround strategy, so it is unlikely things will change significantly for the company.
Who is shorting Zom?
Short selling ZOM is an investing strategy that aims to generate trading profit from Zomedica as its price is falling. Zomedica’s stock is trading up $0.02 today. To short Zomedica stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender.
What are the most shorted stocks? Most Shorted Stocks Right Now
- Nikola Corporation (NASDAQ:NKLA) Number of Hedge Fund Holders: 12. Float Shorted: 30.02% …
- Bed Bath & Beyond Inc. (NASDAQ:BBBY) Number of Hedge Fund Holders: 17. …
- SmileDirectClub, Inc. (NASDAQ:SDC) Number of Hedge Fund Holders: 18. …
- Beyond Meat, Inc. (NASDAQ:BYND) …
- Lemonade, Inc. (NYSE:LMND)
Is Zomedica in a short squeeze?
Zomedica Corp (ZOM) Stock Moves To One Month High On Short Squeeze.